PubMed · 2013 · 88 citations · 85 references
Life SciencesMolecular BiologyOncologyDna RepairDna ReplicationMolecular OncologyCancer Genomic InstabilityDna CrosslinkingDna Double-strand Break RepairDna Repair DefectsDouble-strand Break RepairInterstrand Crosslink RepairDna Damage Repair PathwaysDna Double-strand BreaksDna Strand SeparationDouble-strand Dna BreaksFanconi Anemia PathophysiologyFanconi Anemia Pathway DefectsGenomic Instability PathwaysGenomic Instability Syndromes
Interstrand crosslinks (ICLs) represent a major challenge for DNA replication and transcription by preventing DNA strand separation. Cells deficient in ICL repair are hypersensitive to a variety of bifunctional alkylating agents and exhibit excessive genomic instability. Patients with deficient ICL repair, such as those with Fanconi anemia, are predisposed to a broad spectrum of cancers. The profound cellular toxicity of ICLs is exploited clinically in cancer chemotherapy. Therefore, understanding the mechanism of ICL repair and its impact on cancer development and treatment is very important. Studies of diseases with defective ICL repair, especially Fanconi anemia, have revealed unique ICL repair mechanisms in humans. In this review, we describe pathways and factors involved in ICL damage response and their implications in cancer development and treatment.
85
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Irene García-Higuera, Toshiyasu Taniguchi, Shridar Ganesan et al. · Molecular Cell · 2001 · 1.2K citations · Full text